Enovis Executive and Leadership Team

Damien McDonald, the Chief Executive Officer at Enovis, directs the overarching corporate strategy and global vision for this medical technology innovator. McDonald architects the long-term roadmap for product development, ensuring the portfolio aligns with the mission of restoring patient motion and enhancing clinical outcomes. By fostering partnerships with healthcare experts, the Chief Executive Officer drives the integration of smarter, personalized care solutions across international markets. This leadership role involves constant evaluation of market trends to maintain a competitive edge in the medical device sector. Damien McDonald maintains rigorous standards for operational excellence, guiding the organization toward sustainable growth and improved patient health journeys. Through consistent focus on innovation, the Chief Executive Officer secures the company position as a leader in the global healthcare landscape, ultimately delivering value to stakeholders and patients alike.

Ben Berry, the Chief Financial Officer at Enovis, manages the fiscal health and capital allocation strategies necessary to support global medical technology expansion. Berry oversees financial planning, reporting, and risk management, ensuring the company maintains the resources required for continuous innovation in patient care solutions. By analyzing market performance and operational costs, the Chief Financial Officer optimizes resource distribution to fuel research and development initiatives. This leadership role requires close collaboration with the executive team to align financial objectives with the broader mission of enhancing patient outcomes. Ben Berry implements robust financial controls that safeguard the organization while facilitating strategic investments in new technologies. Through disciplined fiscal management, the Chief Financial Officer supports the long-term stability and growth of the enterprise, ensuring the company remains well-positioned to address the evolving needs of surgeons and clinicians worldwide.

Judith MacGowan, the Regional Chief Financial Officer (APAC) at Enovis, directs financial operations and strategic planning across the Asia-Pacific region. MacGowan oversees regional budget management, regulatory compliance, and fiscal performance, ensuring that local market activities align with the global mission of improving patient outcomes. By analyzing regional economic trends, the Regional Chief Financial Officer (APAC) identifies opportunities for growth and operational efficiency within the complex healthcare landscapes of the APAC territory. This leadership role involves coordinating with global finance teams to standardize reporting while adapting to specific regional market requirements. Judith MacGowan ensures that the company maintains a strong financial foundation to support the distribution of medical technologies throughout the region. Through meticulous oversight of regional assets and investments, the Regional Chief Financial Officer (APAC) facilitates the expansion of innovative care solutions, directly contributing to the overall success of the organization.

Louie Vogt, the Group President, Reconstructive at Enovis, directs the development and commercialization of advanced reconstructive technologies designed to restore patient mobility. Vogt oversees the product lifecycle, from initial research and development to market launch, ensuring that every solution meets the highest standards of clinical efficacy. By partnering with leading surgeons, the Group President, Reconstructive architects strategies that address complex orthopedic challenges and improve patient recovery journeys. This leadership role involves managing cross-functional teams to deliver innovative implants and surgical tools that enhance the quality of care. Louie Vogt monitors market performance and clinical feedback to refine the reconstructive portfolio, maintaining a focus on continuous improvement. Through the strategic management of this core business unit, the Group President, Reconstructive drives significant growth and reinforces the company reputation as a premier provider of medical technology solutions for patients requiring reconstructive intervention.

Gary Justak, the Global President and General Manager, Foot & Ankle at Enovis, directs the strategic growth and operational execution of the foot and ankle product division. Justak oversees the development of specialized medical devices and integrated technologies that assist surgeons in achieving superior patient outcomes. By analyzing global market demands, the Global President and General Manager, Foot & Ankle architects initiatives to expand the reach of these solutions across international healthcare systems. This leadership role involves managing the entire value chain, from product innovation to clinical education, ensuring that clinicians have the tools necessary for effective patient care. Gary Justak fosters a culture of excellence within the division, driving the adoption of advanced surgical techniques. Through the strategic management of this portfolio, the Global President and General Manager, Foot & Ankle contributes to the company mission of restoring motion and enhancing lives through targeted, high-impact medical technology.

Matthew Jewett, the President, Recovery Sciences at Enovis, directs the strategic focus on post-operative care and rehabilitation technologies. Jewett oversees the development and distribution of solutions that support patients throughout the recovery journey, ensuring that clinical outcomes remain the primary objective. By integrating advanced recovery sciences into the broader company portfolio, the President, Recovery Sciences architects programs that help patients regain mobility and improve their quality of life. This leadership role involves collaborating with healthcare providers to implement effective rehabilitation protocols that leverage the latest medical technology. Matthew Jewett monitors the performance of recovery-focused products, driving innovation to meet the evolving needs of the clinical community. Through the strategic management of this division, the President, Recovery Sciences ensures that the company provides comprehensive support for patients, reinforcing the commitment to restoring motion and enhancing long-term health outcomes across the global market.

Oliver Engert, the Chief Administrative Officer at Enovis, manages the internal infrastructure and organizational processes that support the company mission of restoring patient motion. Engert oversees corporate governance, human capital strategies, and operational workflows, ensuring that the internal environment fosters innovation and continuous improvement. By streamlining administrative functions, the Chief Administrative Officer enables the organization to scale effectively while maintaining high standards of service for healthcare providers. This leadership role involves aligning internal policies with the strategic goals of the business to ensure seamless execution across all departments. Oliver Engert drives initiatives that enhance organizational agility, allowing the company to respond rapidly to the needs of surgeons and clinicians. Through the optimization of administrative systems, the Chief Administrative Officer supports the broader objective of delivering effective, personalized care solutions, ultimately strengthening the operational backbone of the entire enterprise.